Skip to content
value.today

IRulya Therapeutics Inc.: connections

The people, owners, parents and subsidiaries, index lists, brands and deals tied to the company. Every line names its source.

In short

  • 1 of the 6 people who filed Form 4 as insiders of IRulya Therapeutics Inc. since 2023 were insiders of another company too, for example at Rocket Pharmaceuticals, Inc. (SEC Form 4 insider filings)
  • The largest 13F holder, Janus Henderson Group Ltd., reported 15.8% of the shares for September 2026; the ten largest together 20.2%. (SEC Form 13F holdings)
  • 2 acquisitions by IRulya Therapeutics Inc. on file; the largest with a price, Ery Del (2023), for $67 million. (Deals on value.today (SEC filings, Wikidata))

Connections graph

Point at or tap a node to light up its ties; pick it to see each tie's source.

IRulya Therapeutics Inc.John MilitelloJanus Henderson Group…Ikarian Capital, LLCSquadron Capital Mana…Millennium Management…Balyasny Asset Manage…Acuta Capital Partner…Birchview Capital, LPBoothbay Fund Managem…Jane Street Group, LLCSeven Fleet Capital M…NovosteoEry DelRocket Pharmaceutic…
  • ● leader
  • ○ Form 4 insider
  • ■ holder, deal or startup
  • ◆ registered entity or brand
  • ▲ index list
  • dashed line: same group

Insiders who are insiders elsewhere too

People who filed SEC Form 4 as directors, officers or 10% owners of this company and of another one in the same years.

Largest institutional holders

From the newest quarter of SEC Form 13F filings, with their largest other holdings.

Deals and startup investments

Companies it bought or that bought it, and startups it invested in.